相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-RSV activities of chicoric acid from Echinacea purpurea in vitro
Tianxi Zhang et al.
MINERVA SURGERY (2022)
Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways
Jifu Song et al.
MOLECULAR MEDICINE REPORTS (2021)
Echinacea in hepatopathy: A review of its phytochemistry, pharmacology, and safety
Wenqian Xu et al.
PHYTOMEDICINE (2021)
Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
Mercedes Ogal et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2021)
Impact of dietary supplementation with Echinacea purpurea on growth performance, immunological, biochemical, and pathological findings in broiler chickens infected by pathogenic E. coli
Mohamed A. Hashem et al.
TROPICAL ANIMAL HEALTH AND PRODUCTION (2020)
Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
Lianlin Su et al.
FRONTIERS IN PHARMACOLOGY (2020)
Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling
Xiaotong Song et al.
FRONTIERS IN PHARMACOLOGY (2020)
SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
Peng Wang et al.
CANCER CELL INTERNATIONAL (2020)
Echinacea angustifolia DC. Lipophilic Extract Patch for Skin Application: Preparation, In Vitro and In Vivo Studies
Dritan Hasa et al.
PHARMACEUTICS (2020)
Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma
Qunfang Zhang et al.
ONCOIMMUNOLOGY (2020)
Sorafenib for Treatment of Hepatocellular Carcinoma A Survival Analysis From the South American Liver Research Network
James S. Leathers et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)
Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells
Ying Ye et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Nqo1 ablation inhibits activation of the PI3K/Akt and MAPK/ERK pathways and blocks metabolic adaptation in hepatocellular carcinoma
Manali Dimri et al.
CANCER RESEARCH (2019)
LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway
Xiaoyu Liao et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma
Jin-lan Huang et al.
MOLECULAR CANCER (2018)
IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma
Qing-guo Xu et al.
MOLECULAR ONCOLOGY (2018)
miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma
Miao Yu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Pharmacological and immunological targeting of tumor mesenchymalization
Justin M. David et al.
PHARMACOLOGY & THERAPEUTICS (2017)
New modalities of treatment for hepatocellular carcinoma
Arman Karimi Behnagh et al.
JOURNAL OF CONTEMPORARY MEDICAL SCIENCES (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters
Hui-Chao Zhou et al.
JOURNAL OF PATHOLOGY (2016)
Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a
Xiao Cui et al.
ONCOTARGET (2016)
High-mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma
Zhikui Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
Qi Zhang et al.
CARCINOGENESIS (2013)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 48, pg 599, 2012)
EUROPEAN JOURNAL OF CANCER (2012)
Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
Dongsheng Wang et al.
MOLECULAR CANCER (2011)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci
Wen-Hui Su et al.
NUCLEIC ACIDS RESEARCH (2007)
Potential health risks of complementary alternative medicines in cancer patients
U Werneke et al.
BRITISH JOURNAL OF CANCER (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas
N Théret et al.
HEPATOLOGY (2001)
分享论文
